Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

ENDRA Life Sciences Q3 EPS $(0.05), Inline

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year.
byBenzinga Newsdesk
November 14, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

White House Says Currently No Plans To Share COVID-19 Shots With North Korea Battling Outbreak

By Vandana Singh
Today, 6:21 PM
The Biden administration says it currently has no plans to share COVID-19 vaccines with North Korea, Reuters reported citing White House press secretary Jen Psaki. However, it supported providing aid to North Korea. North Korea reported its first COVID-19 outbreak, calling it the "gravest national emergency" and ordering a national lockdown.

AZN